Last reviewed · How we verify

NCT03742947: BIO-TRAAP

Haemostasis and Tranexamic Acid in Caesarean Delivery

Completed NA Last updated 29 April 2020
What this trial tests

NA trial testing peripartum haemostasis in Postpartum Hemorrhage in 34 participants. Completed in 17 January 2020.

Timeline
10 January 2019
Primary endpoint
17 January 2020
17 January 2020

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposediagnostic
Enrollment34
Start date10 January 2019
Primary completion17 January 2020
Estimated completion17 January 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

Adults 18 to 65, female only, with Postpartum Hemorrhage or Hyperfibrinolysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate haemostasis and fibrinolysis in peripartum of caesarean delivery and the effect of tranexamic acid (TXA) given in prevention of post-partum haemorrhage (PPH).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postpartum Hemorrhage

Currently open trials in the same condition.

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03742947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing